Mitochondria are the primary metabolic powerhouses of eukaryotic cells, generating over 90% of cellular adenosine triphosphate (ATP) via Oxidative Phosphorylation (OXPHOS). Unlike other cellular organelles, mitochondria possess their own 16,569 base pair circular genome (mtDNA) encoding 13 core OXPHOS subunits, 22 tRNAs, and 2 rRNAs. Due to the proximity of reactive oxygen species (ROS) and a lack of protective histones, mtDNA mutates at 10 to 20 times the rate of nuclear DNA.
1. Heteroplasmy Dynamics & The Biochemical Threshold Effect
Each cell contains hundreds to thousands of individual mtDNA copies. When a pathogenic mutation arises, it coexists alongside wild-type mtDNA copies in a cellular state known as **heteroplasmy**. Clinical symptoms of mitochondrial diseases (such as MELAS, MERRF, or Leigh syndrome) remain silent until the proportion of mutant mtDNA crosses a tissue-specific biochemical threshold—typically **60% to 80% mutant load**—at which point complex I–V respiratory chain activity collapses.
2. Mitochondrial Replacement Therapy (MRT / "Three-Parent IVF")
To prevent maternal transmission of catastrophic mtDNA mutations, reproductive biotechnology employs Mitochondrial Replacement Therapy:
- Maternal Spindle Transfer (MST): The nuclear chromosome spindle is extracted from the unfertilized mother's egg bearing mutant mitochondria and transferred into an enucleated donor egg containing healthy wild-type mitochondria, followed by IVF fertilization.
- Pronuclear Transfer (PNT): Nuclear pronuclei are extracted from a fertilized zygote and transferred into an enucleated donor zygote.
3. In Vivo Mitochondrial Genome Editing: MitoTALENs & DdCBE
Because CRISPR guide RNAs cannot readily cross the double mitochondrial membrane without synthetic targeting peptides, researchers utilize mitochondria-targeted Transcription Activator-Like Effector Nucleases (**mitoTALENs**) and DdCBE (Dimeric DddA-derived Cytosine Base Editors) bearing Mitochondrial Targeting Sequences (MTS). These engineered nucleases selectively bind and cleave mutant mtDNA sequences, shifting heteroplasmy below pathogenic thresholds and restoring normal cellular respiration.